Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 97

Public markets greet eHi for $120m IPO

China-based car rental service eHi has secured $120m from its initial public offering and $50m from a private placement, as travel site Ctrip invested another $20m.

Nov 19, 2014

Astellas-backed FibroGen goes public

The bioopharmaceutical company raised $145.8m in its initial public offering, while AstraZeneca invested $20m in a concurrent private placement.

Nov 17, 2014

Gumi to float at $900m valuation

The mobile games company, which has raised $99m from backers including Gree, NTT Docomo, Sega, Zyga, Tecmo Koei and Nissei, plans to list in Japan next month.

Nov 17, 2014

Hortonworks to go public in $100m IPO

The big data platform, which has raised nearly $250m from backers including Yahoo, HP and Teradata, plans to use the proceeds to expand its sales network.

Nov 13, 2014

Lending platform OnDeck files for $150m IPO

OnDeck, which uses big data to lend to small businesses, has raised almost $100m in equity from investors including SAP and Google.

Nov 13, 2014

Crowdworks to source markets for $9m IPO

The crowdsourcing platform, backed by CyberAgent, Digital Garage, Dentsu and Itochu, has secured about $14.5m in funding since it was founded in 2011.

Nov 11, 2014

Sky Solar lowers IPO target by almost $100m

The solar power provider slashed its initial public offering from $150m to $55.2m after suspending it citing market conditions.

Nov 11, 2014

Coherus secures $85m from IPO

The biosimilar developer, backed by Eli Lilly, Daaichi Sankyo and Medpace, will use the proceeds from its initial public offering to advance three of its product candidates.

Nov 10, 2014

Nevro stimulates market for $126m IPO

Shareholders Novo and Johnson & Johnson invested a total of $4.6m as the neurostimulation device maker went public in a flotation that could rise to almost $145m.

Nov 10, 2014

Inotek eyes $132m in public and debt offerings

The MedImmune-backed glaucoma treatment developer aims to raise up to $86.3m from its initial public offering, as well as an additional $46m in convertible debt.

Nov 7, 2014
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here